A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme

Clinical trial NCT02344355 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02344355
Sponsor: Bryan Allen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2017-03-13
Primary completion: 2026-12-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.